Banner
Synchrotron Could Shed Light On Exotic Dark Photons

There are many hypothetical particles proposed to explain dark matter and one idea to explore how...

The Pain Scale Is Broken But This May Fix It

Chronic pain is reported by over 20 percent of the global population but there is no scientific...

Study Links Antidepressants, Beta-blockers and Statins To Increased Autism Risk

An analysis of 6.14 million maternal-child health records  has linked prescription medications...

Pilot Study: Fibromyalgia Fatigue Improved By TENS Therapy

Fibromyalgia is the term for a poorly-understood condition where people experience pain and fatigue...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Treating patients who suffer from a common condition known as arteriovenous malformation (AVM), which causes blood vessels in the brain to tangle, increases their risk of stroke, a study has found.

People rteriovenous malformation have a better outcome if doctors treat their symptoms only and not the AVM, according to the team of doctors looked at the long-term outcome of patients with the condition, which is caused by abnormal connections between the arteries and veins in the brain. 

Over the next decade, facial transplants will become more common, done at regional hospitals the way heart transplants are done now, according to a retrospective analysis of all known facial transplants worldwide.

The surgeons behind the analysis conclude that the procedure is relatively safe, increasingly feasible, and a clear life-changer that can and should be offered to far more carefully selected patients.  The review team found that the transplants are highly effective at restoring people to fully functioning lives after physically disfiguring and socially debilitating facial injuries, but are not without risks. 

The mobile using public became turned off by QR codes for mobile devices that were nothing but a coupon that they were going to find in the newspaper or on the website.

Similarly, gimmicky contest ads and flashy free-prize messages that can at least be somewhat ignored on a desktop monitor are hard to miss on a mobile, and that may be even more of a turnoff for mobile users.

Yes, you like "Frozen", everyone liked "Frozen". And Idina Menzel blew up the musical "Wicked" when she sang "Defying Gravity" so it's no surprise she blew up "Let It Go" when the catalyst in the Disney hit cartoon came to terms with her arcane gifts - but it's just a cartoon. Much as we might like to think it's permissible to do the same if the reasons are valid, there is a time and a place for such displays.

A corporate board room is likely not that place.

A famous Grouch Marx comedy bit goes that he wouldn't want to be part of any club that would have him as a member. Elitism sells has value.

In a famous "Seinfeld" episode, customers dutifully lined up for lunch and if they deviated from protocol, the Soup Nazi banished them. Such high-falutin' behavior works, according to a new paper in the Journal of Consumer Research. At least when it comes to luxury brands, the ruder the sales staff the better the sales, say scholars from the University of British Columbia's Sauder School of Business. 

Consumers who get the brush-off at a high-end retailer can become more willing to purchase and wear pricey togs.

New research looking at the success of clinical trials of stem cell therapy shows that, when trials appear to be more successful, more discrepancies in trial data are also evident.

Discrepancies were defined as two (or more) reported facts that could not both be accurate because they were logically or mathematically incompatible. For example, one trial reported that it involved 70 patients, who were divided into two groups of 35 and 80.

The researchers found eight trials that each contained over 20 discrepancies.

The meta-analysis of 49 randomized controlled trials of bone marrow stem cell therapy for heart disease in the British Medical Journal identified and listed over 600 discrepancies within the trial reports.